Skip to content

Using a Special Heart Ultrasound to Detect Heart Problems in People with Sepsis or Septic Shock

Role of Speckle tracking echocardiography in patients with sepsis and septic shock: A case control study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/092724
Enrollment
80
Registered
2025-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

ESIC Medical College and Hospital, Faridabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Newly diagnosed cases of sepsis and septic shock as per sepsis 3 definition 2.Age 18-60 years

Exclusion criteria

Exclusion criteria: 1.Use of inotropes and vasopressors 24hrs prior to ICU admission 2.Insufficient echocardiographic image quality 3.Patient or relatives declining participation 4.Prescence of acute myocardial infarction, myocarditis and cardiac arrythmia 5.Post -cardiopulmonary resuscitation 6.Previous history of congenital heart disease, valvular heart disease, cardiomyopathy, and chronic heart failure

Design outcomes

Primary

MeasureTime frame
1.To measure the LV global longitudinal strain (GLS) and RV strain using 2D speckle-tracking echocardiography and classify the degree of myocardial impairment in both sepsis and septic shock patients. 2.To assess left ventricular (LV) and right ventricular (RV) function in patients with sepsis and septic shock using conventional echocardiographic parameters within 24 hours of ICU admission and at the time of recovery. Timepoint: Within 24 hours , at 72 hours and at 7 days or at recovery

Secondary

MeasureTime frame
To evaluate the reversibility of cardiac dysfunction in septic shock patients by performing a follow-up echocardiography at recovery (defined as discontinuation of inotropes or vasopressors).Timepoint: Within 24 hours , at 72 hours and at 7 days or at recovery

Countries

India

Contacts

Public ContactYashita Joshi

ESIC Medical College and Hospital, Faridabad

sachdeva_hc04@yahoo.com9868159563

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026